{
    "clinical_study": {
        "@rank": "97650", 
        "brief_summary": {
            "textblock": "To determine the efficacy and safety of intravaginal fluorouracil administered as\n      prophylaxis in HIV-infected women who have received standard ablative therapy (surgery) for\n      high-grade cervical dysplasia (pre-cancer of the cervix; cervical intraepithelial\n      neoplasia). To correlate time to recurrence of cervical dysplasia with T-cell function.\n\n      Women with HIV infection are at greater risk for cervical dysplasia. Because of the\n      likelihood that untreated or recurrent cervical dysplasia may progress to invasive cancer,\n      there is an urgent need to develop appropriate therapies."
        }, 
        "brief_title": "A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women", 
        "completion_date": {
            "#text": "April 1998", 
            "@type": "Actual"
        }, 
        "condition": [
            "HIV Infections", 
            "Cervix, Dysplasia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Uterine Cervical Dysplasia", 
                "Cervical Intraepithelial Neoplasia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Women with HIV infection are at greater risk for cervical dysplasia. Because of the\n      likelihood that untreated or recurrent cervical dysplasia may progress to invasive cancer,\n      there is an urgent need to develop appropriate therapies.\n\n      Patients are randomized to receive either intravaginal  fluorouracil or no treatment\n      (observation only). Fluorouracil cream is self-administered via applicator at biweekly\n      intervals for 6 months. Patients are evaluated for recurrent cervical dysplasia by cytology\n      and colposcopy with or without biopsy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Antiretrovirals (AZT, ddI, ddC) and immunomodulators (interferon and interleukin).\n\n          -  Prophylaxis or treatment for opportunistic infections.\n\n          -  Vaginal antifungal agents or other indicated vaginal medications (although not\n             permitted on day of fluorouracil application).\n\n          -  Contraceptives.\n\n          -  Acyclovir (prophylaxis or treatment) in patients with a history of primary or\n             recurrent genital herpes.\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  Prior cervical dysplasia (grade II or III cervical intraepithelial neoplasia)\n             successfully treated with an ablative procedure within the past 12 weeks.\n\n          -  Patients less than 18 years of age must have consent of parent or guardian.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms and conditions are excluded:\n\n          -  Untreated or persistent vaginal or vulvar dysplasia.\n\n          -  Colposcopy or biopsy inconclusive or positive for dysplasia.\n\n          -  Active genital ulcerative disease such as syphilitic chancre or herpes ulcer.\n\n          -  Adenocarcinoma in situ.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Cytotoxic chemotherapy for malignancy.\n\n          -  High-dose steroids (> 10 mg/day prednisone or its steroid equivalent).\n\n        Patients with the following prior conditions are excluded:\n\n          -  Malignancy requiring cytotoxic chemotherapy within the 3 months prior to study entry.\n\n          -  Prior hysterectomy.\n\n          -  History of allergic reaction or severe hypersensitivity to fluorouracil.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Fluorouracil (systemic or topical) within 3 months prior to study entry."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "158", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000758", 
            "org_study_id": "ACTG 200", 
            "secondary_id": "11176"
        }, 
        "intervention": {
            "intervention_name": "Fluorouracil", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fluorouracil"
        }, 
        "keyword": [
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Fluorouracil", 
            "Cervix Dysplasia", 
            "Cervix Diseases"
        ], 
        "lastchanged_date": "March 30, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Usc La Nichd Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "Univ. of Miami AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern University CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Cook County Hosp. CORE Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Tulane/LSU Maternal/Child CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins Adult AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Deaconess Med. Ctr., ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Bmc Actg Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Children's Hospital of Michigan NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07103"
                    }, 
                    "name": "NJ Med. School CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10457"
                    }, 
                    "name": "Bronx-Lebanon Hosp. IMPAACT CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14215"
                    }, 
                    "name": "SUNY - Buffalo, Erie County Medical Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Univ. of Rochester ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13210"
                    }, 
                    "name": "SUNY Upstate Med. Univ., Dept. of Peds."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599"
                    }, 
                    "name": "Unc Aids Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45267"
                    }, 
                    "name": "Univ. of Cincinnati CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98122"
                    }, 
                    "name": "UW School of Medicine - CHRMC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "00936"
                    }, 
                    "name": "San Juan City Hosp. PR NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "00936"
                    }, 
                    "name": "Puerto Rico-AIDS CRS"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women", 
        "overall_official": [
            {
                "last_name": "Maiman M", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Watts DH", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "reference": [
            {
                "PMID": "8880203", 
                "citation": "Robinson WR, Morris CB. Cervical neoplasia. Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am. 1996 Oct;10(5):1163-76. Review."
            }, 
            {
                "citation": "Maiman M, Watts DH, Andersen J. A phase three randomized trial of topical vaginal 5-fluorouracil maintenance therapy versus observation after standard treatment for high grade cervical dysplasia in HIV-infected women: ACTG 200. Conf Retroviruses Opportunistic Infect. 1999 Jan 31-Feb 4;6th:155 (abstract no 466)"
            }
        ], 
        "removed_countries": {
            "country": "Puerto Rico"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000758"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "collaborator": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Beth Israel Deaconess Med. Ctr., ACTG CRS": "42.358 -71.06", 
        "Bmc Actg Crs": "42.358 -71.06", 
        "Bronx-Lebanon Hosp. IMPAACT CRS": "40.85 -73.867", 
        "Children's Hospital of Michigan NICHD CRS": "42.331 -83.046", 
        "Cook County Hosp. CORE Ctr.": "41.878 -87.63", 
        "Johns Hopkins Adult AIDS CRS": "39.29 -76.612", 
        "Memorial Sloan-Kettering Cancer Ctr.": "40.714 -74.006", 
        "NJ Med. School CRS": "40.736 -74.172", 
        "Northwestern University CRS": "41.878 -87.63", 
        "Puerto Rico-AIDS CRS": "18.466 -66.106", 
        "SUNY - Buffalo, Erie County Medical Ctr.": "42.886 -78.878", 
        "SUNY Upstate Med. Univ., Dept. of Peds.": "43.048 -76.147", 
        "San Juan City Hosp. PR NICHD CRS": "18.466 -66.106", 
        "Tulane/LSU Maternal/Child CRS": "29.951 -90.072", 
        "UW School of Medicine - CHRMC": "47.606 -122.332", 
        "Unc Aids Crs": "35.913 -79.056", 
        "Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease": "41.878 -87.63", 
        "Univ. of Cincinnati CRS": "39.103 -84.512", 
        "Univ. of Miami AIDS CRS": "25.789 -80.226", 
        "Univ. of Rochester ACTG CRS": "43.161 -77.611", 
        "Usc La Nichd Crs": "34.052 -118.244"
    }
}